| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $3.5M | $1.5M | $672.0K |
| YoY Revenue Growth % | +130.3% | +124.6% | — |
| Gross Profit | $170.0K | $94.0K | — |
| Gross Margin % | 4.9% | 6.2% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$65.6M | -$64.3M | -$137.4M |
| Operating Margin % | -80.0% | -80.0% | -80.0% |
| Net Income (GAAP) | -$57.2M | -$52.0M | -$123.5M |
| EBITDA (Normalized) | -$46.6M | -$51.1M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$46.5M | -$56.7M | -$117.0M |
| Capital Expenditures (CapEx) | $23.7M | $16.5M | — |
| Free Cash Flow (FCF) | -$70.3M | -$73.3M | -$117.0M |
| FCF Margin % | -80.0% | -80.0% | -80.0% |
| Return on Invested Capital (ROIC %) | -30.6% | -21.6% | — |
| Cash & Short-Term Equivalents | $22.9M | $9.2M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $192.0M | $244.4M | — |